2019
DOI: 10.1080/22221751.2019.1686335
|View full text |Cite
|
Sign up to set email alerts
|

Structural basis of host ligand specificity change of GII porcine noroviruses from their closely related GII human noroviruses

Abstract: Diverse noroviruses infect humans and animals via the recognition of host-specific glycan ligands. Genogroup II (GII) noroviruses consist of human noroviruses (huNoVs) that generally bind histo-blood group antigens (HBGAs) as host factors and three porcine norovirus (porNoV) genotypes (GII.11/18/19) that form a genetic lineage lacking HBGA-binding ability. Thus, these GII porNoVs provide an excellent model to study norovirus evolution with host ligand specificity changes. Here we solved the crystal structures … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 57 publications
(92 reference statements)
0
6
0
Order By: Relevance
“…Some of the other animal genotypes have been tested before, and the lack of attachment was expected. These include GIV.2 and GII.11 and GII.19, which did not attach to HBGAs or human saliva, respectively (54)(55)(56). Interestingly, the porcine genotypes have the conserved binding site, but no attachment factor has been identified yet.…”
Section: Discussionmentioning
confidence: 99%
“…Some of the other animal genotypes have been tested before, and the lack of attachment was expected. These include GIV.2 and GII.11 and GII.19, which did not attach to HBGAs or human saliva, respectively (54)(55)(56). Interestingly, the porcine genotypes have the conserved binding site, but no attachment factor has been identified yet.…”
Section: Discussionmentioning
confidence: 99%
“…The cDNA fragments encoding the P proteins of two clinical GI.3 huNoVs, the Desert Shield virus DSV395 (GenBank code: U04469.1 , VP1 amino acids 227–544) and the VA98115/1998 (GenBank code: AY038598.1 , VP1 amino acid 227–538), were chemically synthesized and cloned into expression vector pGEX-6P-1 at EcoRI and SalI / XhoI restriction sites. The P proteins were expressed in E. coli BL21(DE3) as described elsewhere ( 47 49 ). The resulting GST-P fusion proteins were purified using glutathione-Sepharose 4B (GE Healthcare Life Sciences) according to the manufacturer’s instructions, and the GST tag was removed with Prescission protease at 4°C overnight.…”
Section: Methodsmentioning
confidence: 99%
“…A recent structural study has defined the HBGA binding site on the GII.3 strain TV24 (GenBank code: U02030) P domain, which is shaped primarily by eight residues including T357, R358, K363, D386, D388, S449, G451, and R452 [36]. These eight residues are identical among the TV24 strain (cluster 1) and the four GII.3 strains tested here (data not shown), suggesting that GII.3 maintains a conserved HBGA binding site despite the virus undergoing steady evolution.…”
Section: Structural Modeling Of the 8c7 And 8d1 Epitopesmentioning
confidence: 99%
“…The GII.3 VP1 protein can self-assemble into virus-like particles [34][35][36], with the outer P domain in either "resting" or "rising" conformation depending on the pH of sample solutions [35]. GII.3 VLPs formed by the entire VP1 protein or P particles solely made of the P domain can bind HBGAs in vitro [8,21,34,37].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation